Neurotrophic Factors in Peripheral Neuropathies: Therapeutic Implications
- 5 April 1999
- journal article
- review article
- Published by Wiley in Brain Pathology
- Vol. 9 (2) , 393-413
- https://doi.org/10.1111/j.1750-3639.1999.tb00234.x
Abstract
Neurotrophic factors are proteins which promote the survival of specific neuronal populations. Many have other physiological effects on neurons such as inducing morphological differentiation, enhancing nerve regeneration, stimulating neurotransmitter expression, and otherwise altering the physiological characteristics of neurons. These properties suggest that neurotrophic factors are highly promising as potential therapeutic agents for neurological disease.Neurotrophic factors will most likely be applied to the peripheral nervous system initially, since there are fewer problems for large proteins to gain access to peripheral neurons. Many of the most intensively studied factors are active in the peripheral nervous system. These include the neurotrophins (nerve growth factor, brain derived neurotrophic factor, neu‐rotrophin‐3, neurotrophin‐4/5), the insulin like growth factors, ciliary neurotrophic factor, and glial cell derived neurotrophic factor and its related proteins. The biology of these factors and their receptors in the peripheral nervous system is reviewed here. We also review data suggesting that abnormal availability of some factors may contribute towards the pathogenesis of certain types of peripheral neuropathy. Finally, the pre‐clinical data suggesting that individual factors might be effective in treating neuropathy is reviewed, along with data relating to possible side effects of neurotrophic factor therapy. Several factors have already entered clinical trials with variable success. The data from these trials is reviewed as wellKeywords
This publication has 154 references indexed in Scilit:
- Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitroLife Sciences, 1994
- Axonal Transport of Endogenous Nerve Growth Factor (NGF) and NGF Receptor in Experimental Diabetic NeuropathyExperimental Neurology, 1994
- Differential effects on sensory nerve processes and behavioral alterations in the rat after treatment with antibodies to nerve growth factorExperimental Neurology, 1991
- Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: Role of mesencephalic gliaJournal of Neuroscience Research, 1991
- Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantationNeuroscience Letters, 1991
- Cloning and expression of a cDNA encoding a novel human neurotrophic factorFEBS Letters, 1990
- Cisplatin NeurotoxicityNew England Journal of Medicine, 1990
- Impaired Neurogenic Vascular Response in Patients with Diabetes and Neuropathic Foot LesionsNew England Journal of Medicine, 1988
- Placode and neural crest-derived sensory neurons are responsive at early developmental stages to brain-derived neurotrophic factorDevelopmental Biology, 1985
- Morphological and ultrastructural changes in PC12 pheochromocytoma cells induced by a combined treatment with NGF and taxolExperimental Cell Research, 1982